Barkhof F - Search Results

1

The wearing-off phenomenon of ocrelizumab in patients with multiple sclerosis.

Toorop AA, van Lierop ZYGJ, Strijbis EMM, Teunissen CE, Barkhof F, Uitdehaag BMJ, van Kempen ZLE, Killestein J. Toorop AA, et al. Among authors: barkhof f. Mult Scler Relat Disord. 2022 Jan;57:103364. doi: 10.1016/j.msard.2021.103364. Epub 2021 Nov 1. Mult Scler Relat Disord. 2022. PMID: 35158470 Free article.

2

Serial quantitative MR assessment of optic neuritis in a case of neuromyelitis optica, using Gadolinium- "enhanced" STIR imaging.

Barkhof F, Scheltens P, Valk J, Waalewijn C, Uitdehaag BM, Polman CH. Barkhof F, et al. Neuroradiology. 1991;33(1):70-1. doi: 10.1007/BF00593340. Neuroradiology. 1991. PMID: 2027451

3

Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2.

van Oosten BW, Barkhof F, Truyen L, Boringa JB, Bertelsmann FW, von Blomberg BM, Woody JN, Hartung HP, Polman CH. van Oosten BW, et al. Among authors: barkhof f. Neurology. 1996 Dec;47(6):1531-4. doi: 10.1212/wnl.47.6.1531. Neurology. 1996. PMID: 8960740

4

Specific power calculations for magnetic resonance imaging (MRI) in monitoring active relapsing-remitting multiple sclerosis (MS): implications for phase II therapeutic trials.

Truyen L, Barkhof F, Tas M, Van Walderveen MA, Frequin ST, Hommes OR, Nauta JJ, Polman CH, Valk J. Truyen L, et al. Among authors: barkhof f. Mult Scler. 1997 Jan;2(6):283-90. doi: 10.1177/135245859700200604. Mult Scler. 1997. PMID: 9065919

5

Interleukin-2 therapy does not exacerbate multiple sclerosis.

van Oosten BW, Uitdehaag BM, Barkhof F, Hartung HP, Wagstaff J, Polman CH. van Oosten BW, et al. Among authors: barkhof f. Neurology. 1997 Aug;49(2):633-4. doi: 10.1212/wnl.49.2.633. Neurology. 1997. PMID: 9270618 No abstract available.

6

Single-dose gadolinium with magnetization transfer versus triple-dose gadolinium in the MR detection of multiple sclerosis lesions.

van Waesberghe JH, Castelijns JA, Roser W, Silver N, Yousry T, Lycklama à Nijeholt GJ, Adèr HJ, Uitdehaag BM, Radue EW, Polman CH, Kappos L, Miller DH, Barkhof F. van Waesberghe JH, et al. Among authors: barkhof f. AJNR Am J Neuroradiol. 1997 Aug;18(7):1279-85. AJNR Am J Neuroradiol. 1997. PMID: 9282855 Free PMC article.

7

Methylprednisolone treatment in multiple sclerosis: effect of treatment, pharmacokinetics, future.

Hommes OR, Barkhof F, Jongen PJ, Frequin ST. Hommes OR, et al. Among authors: barkhof f. Mult Scler. 1996 Jul;1(6):327-8. doi: 10.1177/135245859600100607. Mult Scler. 1996. PMID: 9345410 Review.

8

A phase II trial of anti-CD4 antibodies in the treatment of multiple sclerosis.

van Oosten BW, Lai M, Barkhof F, Miller DH, Moseley IF, Thompson AJ, Hodgkinson S, Polman CH. van Oosten BW, et al. Among authors: barkhof f. Mult Scler. 1996 Jul;1(6):339-42. doi: 10.1177/135245859600100611. Mult Scler. 1996. PMID: 9345413 Clinical Trial.

9

Magnetic resonance imaging of epilepsy in multiple sclerosis: a case control study. Implications for treatment trials with 4-aminopyridine.

Truyen L, Barkhof F, Frequin ST, Polman CH, Tobi H, Hommes OR, Valk J. Truyen L, et al. Among authors: barkhof f. Mult Scler. 1996 Feb;1(4):213-7. Mult Scler. 1996. PMID: 9345437

10

Ibuprofen does not suppress active multiple sclerosis lesions on gadolinium-enhanced MR images.

Barkhof F, van Waesberghe JH, Uitdehaag BM, Polman CH. Barkhof F, et al. Ann Neurol. 1997 Dec;42(6):982. doi: 10.1002/ana.410420622. Ann Neurol. 1997. PMID: 9403493 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,520 results

Search Page

Filters